Literature DB >> 8669562

A 5-year survival study of general surgical patients aged 65 years and over.

A E Edwards1, D G Seymour, J M McCarthy, M K Crumplin.   

Abstract

A prospective 5-year survival study of 900 patients, aged 65 years and over, undergoing a general surgical procedure, demonstrated that following an initial high mortality rate the survival of the group as a whole approached that of an age-matched population. Non-elective admissions, age 75 years and over, ASA grade 4-5 and major surgery were associated with a high early mortality. Mortality associated with malignancy extended over 1 year. The study reinforces the conclusion that age alone should be no bar to surgery and anaesthesia, endorses the findings of the National Confidential Enquiry into Peri-operative deaths and emphasises the need to re-examine the provision of anaesthetic and surgical services in District General Hospitals. The benefits of elective admission in the very old are highlighted, along with the potential for extension of day case surgery.

Entities:  

Mesh:

Year:  1996        PMID: 8669562     DOI: 10.1111/j.1365-2044.1996.tb07645.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  4 in total

Review 1.  The management of postsurgical pain in the elderly population.

Authors:  J Richardson; K Bresland
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923

2.  Patient-reported outcomes after combined surgery for pelvic floor disorders in older compared to younger women.

Authors:  Vivian W Sung; Katharine Joo; Felisha Marques; Deborah L Myers
Journal:  Am J Obstet Gynecol       Date:  2009-09-02       Impact factor: 8.661

Review 3.  Anaesthesia for cataract surgery.

Authors:  Emmanuel Nouvellon; Philippe Cuvillon; Jacques Ripart; Eric J Viel
Journal:  Drugs Aging       Date:  2010-01-01       Impact factor: 3.923

4.  Emergency Laparotomy in Denmark: A Nationwide Descriptive Study.

Authors:  Mie S Liljendahl; Ismail Gögenur; Lau C Thygesen
Journal:  World J Surg       Date:  2020-09       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.